Barbara Duncan
Chairman bij FUSN PHAR
Vermogen: 376 412 $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Barbara Duncan
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues.
251
| Extinct | Investment Banks/Brokers | 251 |
Louisiana State University
138
| College/University | Other Consumer Services | 138 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.
88
| Subsidiary | Miscellaneous Commercial Services | 88 |
Public Company | Beverages: Non-Alcoholic | 60 | |
The Wharton School of the University of Pennsylvania
33
| College/University | Other Consumer Services | 33 |
Unknown | 28 | ||
Public Company | Pharmaceuticals: Major | 26 | |
26
| Public Company | Pharmaceuticals: Major | 26 |
Public Company | Pharmaceuticals: Major | 24 | |
Public Company | Biotechnology | 23 | |
Subsidiary | Miscellaneous Commercial Services | 21 | |
Subsidiary | Biotechnology | 16 | |
Extinct | Pharmaceuticals: Major | 15 | |
Public Company | Biotechnology | 14 | |
DOV Pharmaceutical, Inc.
DOV Pharmaceutical, Inc. Miscellaneous Commercial ServicesCommercial Services DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ.
12
| Extinct | Miscellaneous Commercial Services | 12 |
10
| Public Company | Pharmaceuticals: Major | 10 |
Public Company | Pharmaceuticals: Major | 8 | |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million.
7
| Subsidiary | Biotechnology | 7 |
SBC Warburg Dillon Read Corporate Finance AG
1
| Extinct | Investment Banks/Brokers | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Barbara Duncan via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
CELGENE | Biotechnology | Corporate Officer/Principal Founder General Counsel | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
GILEAD SCIENCES, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO Compliance Officer Corporate Officer/Principal | |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member Director of Finance/CFO General Counsel | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Comptroller/Controller/Auditor Sales & Marketing | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
CADUS CORPORATION | Biotechnology | Chief Executive Officer Chief Administrative Officer | |
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
BELLUS HEALTH | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel Chief Executive Officer Investor Relations Contact | |
MERSANA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
ALZHEON, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree Masters Business Admin Undergraduate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
Stanford University | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The Johns Hopkins University | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Corporate Officer/Principal Graduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
University of Michigan | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal President Corporate Officer/Principal | |
ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
Edimer Pharmaceuticals, Inc.
Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Doctorate Degree Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Consultant / Advisor Private Equity Investor | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO General Counsel | |
ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Doctorate Degree Masters Business Admin | |
DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
NUCANA PLC | Biotechnology | Director/Board Member Director/Board Member | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Founder General Counsel | |
APPLIED THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
INTELLIA THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Founder Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 41 |
Verenigd Koninkrijk | 6 |
Ierland | 2 |
Canada | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 31 |
Consumer Services | 16 |
Commercial Services | 3 |
Finance | 3 |
Health Services | 2 |
Operationeel
Director/Board Member | 601 |
Corporate Officer/Principal | 251 |
Independent Dir/Board Member | 211 |
Chairman | 115 |
Undergraduate Degree | 79 |
Sterkste connecties
Insiders | |
---|---|
Srini Akkaraju Akkaraju | 54 |
James Healy | 50 |
Franklin Berger | 41 |
James Noble | 39 |
Chau Khuong | 38 |
Perry Karsen | 38 |
George Bickerstaff | 37 |
Isaac Blech | 32 |
Jules Haimovitz | 27 |
Alastair Clemow | 27 |
Daniel Welch | 24 |
Pablo Cagnoni | 24 |
Kimberlee Drapkin | 23 |
Rafaèle Elisabeth Tordjman | 23 |
Michael White | 22 |
- Beurs
- Insiders
- Barbara Duncan
- Bedrijfsconnecties